CLINICAL_TRIALS ClinicalTrials.gov record update

Phase IV Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02213653
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:56.084148+00:00
Published At: 2015-04-29T00:00:00+00:00
Record Updated At: 2015-04-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Solid Cancer Metastatic Disease", "Lymphoid Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-04-29"
protocolSection.identificationModule.nctId: "NCT02213653"
protocolSection.identificationModule.officialTitle: "Phase IV Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject \u00ae) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.